V. Bauchau and S. Durham, Epidemiological characterization of the intermittent and persistent types of allergic rhinitis, Allergy, vol.114, issue.Suppl. 5, pp.350-353, 2005.
DOI : 10.1111/j.1398-9995.2005.00751.x

J. Bousquet, C. Van, N. Khaltaev, . Aria-workshop, and . Group, Allergic Rhinitis and Its Impact on Asthma, Journal of Allergy and Clinical Immunology, vol.108, issue.5, pp.147-334, 2001.
DOI : 10.1067/mai.2001.118891

URL : https://hal.archives-ouvertes.fr/inserm-00815533

J. Bousquet, N. Khaltaev, A. Cruz, J. Denburg, W. Fokkens et al., Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*, Allergy, vol.5, issue.Suppl. 4, pp.8-160, 2008.
DOI : 10.1111/j.1398-9995.2007.01620.x

URL : https://hal.archives-ouvertes.fr/inserm-00815533

J. Brozek, J. Bousquet, C. Baena-cagnani, S. Bonini, G. Canonica et al., Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision, Journal of Allergy and Clinical Immunology, vol.126, issue.3, pp.466-76, 2010.
DOI : 10.1016/j.jaci.2010.06.047

G. Canonica, J. Bousquet, T. Casale, R. Lockey, C. Baena-cagnani et al., Sub-Lingual Immunotherapy, World Allergy Organization Journal, vol.2, issue.11, pp.1-59, 2009.
DOI : 10.1097/WOX.0b013e3181c6c379

G. Canonica, L. Cox, R. Pawankar, C. Baena-cagnani, M. Blaiss et al., Sublingual immunotherapy: World Allergy Organization position paper 2013 update, World Allergy Organization Journal, vol.7, issue.1, pp.6-10, 2014.
DOI : 10.1186/2045-7022-2-20

P. Bousquet, C. Castelli, J. Daures, J. Heinrich, R. Hooper et al., Assessment of Allergen Sensitization in a General Population-Based Survey (European Community Respiratory Health Survey I), Annals of Epidemiology, vol.20, issue.11, pp.797-803, 2010.
DOI : 10.1016/j.annepidem.2010.05.012

S. Arbes, . Jr, P. Gergen, L. Elliott, and D. Zeldin, Prevalences of positive skin test responses to 10 common allergens in the US population: Results from the Third National Health and Nutrition Examination Survey, Journal of Allergy and Clinical Immunology, vol.116, issue.2, pp.377-83, 2005.
DOI : 10.1016/j.jaci.2005.05.017

T. Craig, T. King, R. Lemanske, . Jr, M. Wechsler et al., Aeroallergen sensitization correlates with PC20 and exhaled nitric oxide in subjects with mild-to-moderate asthma, Journal of Allergy and Clinical Immunology, vol.121, issue.3, pp.671-678, 2008.
DOI : 10.1016/j.jaci.2007.12.1153

M. Worm, H. Lee, and K. Kostev, Prevalence and treatment profile of patients with grass pollen and house dust mite allergy, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, vol.105, issue.7, pp.653-61, 2013.
DOI : 10.1111/ddg.12089

M. Migueres, J. Fontaine, T. Haddad, M. Grosclaude, F. Saint-martin et al., Characteristics of Patients with Respiratory Allergy in France and Factors Influencing Immunotherapy Prescription: A Prospective Observational Study (Realis), International Journal of Immunopathology and Pharmacology, vol.23, issue.2, pp.387-400, 2011.
DOI : 10.1177/039463201102400212

A. Didier, A. Chartier, and G. Démonet, Immunothérapie sublinguale : pour quel profil de patients en pratique ? Analyse intermédiaire d'Odissee (observatoire de l'indication, du choix de prise en charge par immunothérapie spécifique sublinguale ainsi que de l'adhésion et de l'observance au traitement chez les patients souffrant d'allergie respiratoire [rhinite et/ou conjonctivite et/ou asthme allergique]) = Specific sublingual immunotherapy: for which profiles of patients in practice? Midterm analysis of ODISSEE (observatory of the indication and management of respiratory allergies [rhinitis and/or conjunctivitis and/or allergic asthma] by specific sublingual immunotherapy) Revue Française d' Allergologie, pp.426-459, 2010.

A. Didier, A. Chartier, and G. Démonet, Immunothérapie spécifique sublinguale : ODISSEE un an après. Résultats préliminaires d'ODISSEE (Observatoire de l'indication, du choix de prise en charge par Immunothérapie spécifique sublinguale ainsi que de l'adhésion et de l'observance au traitement chez les patients souffrant d'allergie respiratoire?rhinite et/ou conjonctivite et/ou asthme allergique) = Specific sublingual Immunotherapy: ODISSEE after one year. Preliminary results of ODISSEE (observatory of the indication and management of respiratory allergies rhinitis and/or conjunctivitis and/or allergic asthma by specific sublingual immunotherapy) Revue Française d, Allergologie, vol.51, pp.476-84, 2011.

U. Langen, Asthma and sensitization pattern in Children Allergic diseases?highlights in the clinic, mechanisms and treatment. ISBN: 978-953-51-0227-4. Rijeka, Croatia: InTech. 2012. http://www.intechopen.com/books/allergic- diseases-highlights-in-the-clinic-mechanisms-andtreatment/ asthma-and-sensitization-pattern-in-children

S. Illi, E. Von-mutius, S. Lau, B. Niggemann, C. Grüber et al., Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study, The Lancet, vol.368, issue.9537, pp.763-70, 2006.
DOI : 10.1016/S0140-6736(06)69286-6

A. Custovic, H. Sonntag, I. Buchan, D. Belgrave, A. Simpson et al., Evolution pathways of IgE responses to grass and mite allergens throughout childhood, Journal of Allergy and Clinical Immunology, vol.136, issue.6, pp.1645-52, 2015.
DOI : 10.1016/j.jaci.2015.03.041

A. Simpson, N. Lazic, D. Belgrave, P. Johnson, and C. Bishop, Patterns of IgE responses to multiple allergen components and clinical symptoms at age 11 years, Journal of Allergy and Clinical Immunology, vol.136, issue.5, pp.1224-1255, 2015.
DOI : 10.1016/j.jaci.2015.03.027

M. Westman, C. Lupinek, J. Bousquet, N. Andersson, S. Pahr et al., Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence, Journal of Allergy and Clinical Immunology, vol.135, issue.5, pp.1199-206, 2015.
DOI : 10.1016/j.jaci.2014.10.042

G. Ciprandi, R. Alesina, R. Ariano, P. Aurnia, P. Borrelli et al., Characteristics of patients with allergic polysensitization: the POLISMAIL study, Eur Ann Allergy Clin Immunol, vol.40, issue.3, pp.77-83, 2008.

M. Jutel, I. Agache, S. Bonini, A. Burks, M. Calderon et al., International consensus on allergy immunotherapy, Journal of Allergy and Clinical Immunology, vol.136, issue.3, pp.556-68, 2015.
DOI : 10.1016/j.jaci.2015.04.047

L. Cox, H. Nelson, R. Lockey, C. Calabria, and T. Chacko, Allergen immunotherapy: A??practice parameter third update, Journal of Allergy and Clinical Immunology, vol.127, issue.1, pp.1-55, 2011.
DOI : 10.1016/j.jaci.2010.09.034

L. Cox and L. Jacobsen, Comparison of allergen immunotherapy practice patterns in the United States and Europe, Annals of Allergy, Asthma & Immunology, vol.103, issue.6, pp.451-460, 2009.
DOI : 10.1016/S1081-1206(10)60259-1

T. Zuberbier, C. Bachert, P. Bousquet, G. Passalacqua, W. Canonica et al., GA2LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma, Allergy, vol.61, issue.Suppl. 82, pp.1525-1555, 2010.
DOI : 10.1111/j.1398-9995.2010.02474.x

M. Calderón, L. Cox, T. Casale, P. Moingeon, and P. Demoly, Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: Looking at the published evidence, Journal of Allergy and Clinical Immunology, vol.129, issue.4, pp.929-963, 2012.
DOI : 10.1016/j.jaci.2011.11.019

M. Migueres, I. Dávila, F. Frati, A. Azpeitia, Y. Jeanpetit et al., Types of sensitization to aeroallergens: definitions, prevalences and Page, p.13

G. Ciprandi and I. Cirillo, Monosensitization and polysensitization in allergic rhinitis, European Journal of Internal Medicine, vol.22, issue.6, pp.75-84, 2011.
DOI : 10.1016/j.ejim.2011.05.009

C. Vidal, E. Enrique, G. A. Moreno, C. Tabar, and A. , Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: an Allergists??? Consensus, Clinical and Translational Allergy, vol.4, issue.1, pp.36-46, 2014.
DOI : 10.1159/000057742

A. European-medicines, Guideline on allergen products: production and quality issues. London, 2007.

A. Lorenz, D. Lüttkopf, S. May, S. Scheurer, and S. Vieths, The Principle of Homologous Groups in Regulatory Affairs of Allergen Products – A Proposal, International Archives of Allergy and Immunology, vol.148, issue.1, pp.1-17, 2009.
DOI : 10.1159/000151243

L. Cox, H. Nelson, R. Lockey, C. Calabria, T. Chacko et al., Allergen immunotherapy: A??practice parameter third update, Journal of Allergy and Clinical Immunology, vol.127, issue.1, pp.1-55, 2011.
DOI : 10.1016/j.jaci.2010.09.034

H. Nelson, Multiallergen immunotherapy for allergic rhinitis and asthma, Journal of Allergy and Clinical Immunology, vol.123, issue.4, pp.763-772, 2009.
DOI : 10.1016/j.jaci.2008.12.013

M. Calderon and L. Cox, Monoallergen Sublingual Immunotherapy Versus Multiallergen Subcutaneous Immunotherapy for Allergic Respiratory Diseases: A Debate During the AAAAI 2013 Annual Meeting in San Antonio, Texas, The Journal of Allergy and Clinical Immunology: In Practice, vol.2, issue.2, pp.136-179, 2014.
DOI : 10.1016/j.jaip.2013.12.008

N. Bahceciler, N. Galip, and N. Cobanoglu, Multiallergen-specific immunotherapy in polysensitized patients: where are we?, Immunotherapy, vol.5, issue.2, pp.183-90, 2013.
DOI : 10.2217/imt.12.161

G. Passalacqua, The use of single versus multiple antigens in specific allergen immunotherapy for allergic rhinitis, Current Opinion in Allergy and Clinical Immunology, vol.14, issue.1, pp.20-24, 2014.
DOI : 10.1097/ACI.0000000000000018

N. Pham-thi, P. Bousiquier, and A. Chartier, Polysensibilisation aux pneumallergènes : étude des profils cliniques et des modalités de prescription d'immunothérapies. Quelle immunothérapie pour les patients polysensibilisés ? Résultats d'une enquête nationale des pratiques auprès des allergologues [Polysensitization to aeroallergens: Study of clinical profiles and immunotherapy modalities of prescription]. Revue Française d' Allergologie, pp.3-10, 2012.

M. Hadler, E. Karagiannis, K. Shah-hosseini, and R. Mösges, Effectiveness and tolerability of a 2-year sublingual allergen immunotherapy (AIT) in routine medical practice in birch pollen allergic patients. Italy: Poster presented at the European Academy of Allergy and Clinical Immunology and World Allergy Organization Congress, 2013.

K. Shah-hosseini, K. Mioc, M. Hadler, E. Karagiannis, and R. Mösges, Optimum treatment strategies for polyallergic patients ??? analysis of a large observational trial, Current Medical Research and Opinion, vol.31, issue.12, pp.1-11, 2015.
DOI : 10.1185/03007995.2015.1094653

G. Ciprandi, C. Incorvaia, P. Puccinelli, S. Scurati, S. Masieri et al., The Polismail Lesson: Sublingual Immunotherapy May Be Prescribed also in Polysensitized Patients, International Journal of Immunopathology and Pharmacology, vol.98, issue.2, pp.637-677, 2010.
DOI : 10.1177/039463201002300227

G. Ciprandi, G. Cadario, M. Gioacchino, S. Gangemi, A. Gasparini et al., Sublingual immunotherapy in children with allergic polysensitization, Allergy and Asthma Proceedings, vol.31, issue.3, pp.227-258, 2010.
DOI : 10.2500/aap.2010.31.3337

G. Ciprandi, C. Incorvaia, P. Puccinelli, S. Soffia, S. Scurati et al., Polysensitization as a challenge for the allergist: the suggestions provided by the Polysensitization Impact on Allergen Immunotherapy studies, Expert Opinion on Biological Therapy, vol.23, issue.6, pp.715-737, 2011.
DOI : 10.1111/j.1365-2222.2005.02240.x

O. Pfaar, P. Demoly, R. Gerth-van-wijk, S. Bonini, J. Bousquet et al., Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper, Allergy, vol.3, issue.Suppl 14, pp.854-67, 2014.
DOI : 10.1111/all.12383

T. Haahtela, G. Burbach, C. Bachert, C. Bindslev-jensen, S. Bonini et al., Clinical relevance is associated with allergen-specific wheal size in skin prick testing, Clinical & Experimental Allergy, vol.4, issue.3, pp.407-423, 2014.
DOI : 10.1111/cea.12240

J. Sastre, M. Landivar, M. Ruiz-garcía, M. Andregnette-rosigno, and I. Mahillo, How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area, Allergy, vol.6, issue.Suppl. 10, pp.709-720, 2012.
DOI : 10.1111/j.1398-9995.2012.02808.x

G. Canonica, I. Ansotegui, R. Pawankar, P. Schmid-grendelmeier, M. Van-hage et al., A WAO - ARIA - GA??LEN consensus document on molecular-based allergy diagnostics, World Allergy Organization Journal, vol.6, issue.1, pp.17-27, 2013.
DOI : 10.1186/1939-4551-6-17

N. Douladiris, S. Savvatianos, I. Roumpedaki, C. Skevaki, D. Mitsias et al., A Molecular Diagnostic Algorithm to Guide Pollen Immunotherapy in Southern Europe: Towards Component-Resolved Management of Allergic Diseases, International Archives of Allergy and Immunology, vol.162, issue.2, pp.163-72, 2013.
DOI : 10.1159/000353113

G. Stringari, S. Tripodi, C. Caffarelli, A. Dondi, R. Asero et al., The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever, Journal of Allergy and Clinical Immunology, vol.134, issue.1, pp.75-81, 2014.
DOI : 10.1016/j.jaci.2014.01.042

C. Moreno, J. Justicia, J. Quiralte, A. Moreno-ancillo, A. Iglesias-cadarso et al., Olive, grass or both? Molecular diagnosis for the allergen immunotherapy selection in polysensitized pollinic patients, Allergy, vol.31, issue.Suppl 71, pp.1357-63, 2014.
DOI : 10.1111/all.12474

U. Darsow, K. Brockow, F. Pfab, J. T. Petersson, C. Borres et al., Heterogeneity of molecular sensitization profiles in grass pollen allergy - implications for immunotherapy?, Clinical & Experimental Allergy, vol.40, issue.5, pp.778-86, 2014.
DOI : 10.1111/cea.12303

P. Comite, P. Minale, F. Ferrero, M. Mussap, and G. Ciprandi, Der p 1 IgE measurement for distinguishing between sensitization and allergy, Immunology Letters, vol.166, issue.2, pp.145-151, 2015.
DOI : 10.1016/j.imlet.2015.06.004

G. Ciprandi, P. Comite, F. Ferrero, P. Minale, S. Voltolini et al., ) pollen antigen (Bet v 1) immunoglobulin E measurement distinguish between sensitization and allergy?, International Forum of Allergy & Rhinology, vol.78, issue.Suppl 86, 2015.
DOI : 10.1002/alr.21612

G. Ciprandi, R. Alesina, D. Amici, and M. , Serum specific IgE: Biomarker for specific immunotherapy responsiveness?, Allergologia et Immunopathologia, vol.42, issue.4, pp.369-71, 2013.
DOI : 10.1016/j.aller.2012.12.004

M. Tosca, M. Silvestri, A. Accogli, G. Rossi, and G. Ciprandi, Serum-specific IgE and allergen immunotherapy in allergic children, Immunotherapy, vol.6, issue.1, pp.29-33, 2014.
DOI : 10.2217/imt.13.145

G. Ciprandi and M. Silvestri, Serum specific IgE: a biomarker of response to allergen immunotherapy, J Investig Allergol Clin Immunol, vol.24, issue.1, pp.35-44, 2014.

M. Crobach, J. Hermans, A. Kaptein, J. Ridderikhoff, H. Petri et al., The diagnosis of allergic rhinitis: how to combine the medical history with the results of radioallergosorbent tests and skin prick tests, Scand J Prim Health Care, vol.16, issue.1, pp.30-36, 1998.

P. Moingeon, Progress in the development of specific immunotherapies for house dust mite allergies, Expert Review of Vaccines, vol.13, issue.12, pp.1463-73, 2014.
DOI : 10.1586/14760584.2014.948861

G. Ciprandi, G. Cadario, D. Gioacchino, M. Gangemi, S. Minelli et al., Sublingual immunotherapy in polysensitized allergic patients with rhinitis and/or asthma: allergist choices and treatment efficacy, J Biol Regul Homeost Agents, vol.23, issue.3, pp.165-71, 2009.

G. Ciprandi, G. Cadario, C. Valle, E. Ridolo, M. Verini et al., Sublingual immunotherapy in polysensitized patients: effect on quality of life, J Investig Allergol Clin Immunol, vol.20, issue.4, pp.274-283, 2010.

A. Bozek, K. Kolodziejczyk, B. Warkocka-szoltysek, and J. Jarzab, Grass pollen sublingual immunotherapy: A double-blind, placebo-controlled study in elderly patients with seasonal allergic rhinitis, American Journal of Rhinology & Allergy, vol.28, issue.5, pp.423-430, 2014.
DOI : 10.2500/ajra.2014.28.4091

C. Irani, R. Saleh, M. Jammal, and F. Haddad, High-dose sublingual immunotherapy in patients with uncontrolled allergic rhinitis sensitized to pollen: a real-life clinical study, International Forum of Allergy & Rhinology, vol.129, issue.Suppl 95, pp.802-809, 2014.
DOI : 10.1002/alr.21375

H. Malling, A. Montagut, M. Melac, G. Patriarca, P. Panzner et al., Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis, Clinical & Experimental Allergy, vol.39, issue.3, pp.387-93, 2009.
DOI : 10.1111/j.1365-2222.2008.03152.x

H. Nelson, M. Blaiss, H. Nolte, S. Würtz, J. Andersen et al., Efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet in mono- and polysensitized subjects, Allergy, vol.129, issue.2, pp.252-257, 2012.
DOI : 10.1111/all.12074

P. Moingeon, Update on Immune Mechanisms Associated with Sublingual Immunotherapy: Practical Implications for the Clinician, The Journal of Allergy and Clinical Immunology: In Practice, vol.1, issue.3, pp.228-269, 2013.
DOI : 10.1016/j.jaip.2013.03.013

. Demoly, 12:2 ? We accept pre-submission inquiries ? Our selector tool helps you to find the most relevant journal ? We provide round the clock customer support ? Convenient online submission ? Thorough peer review ? Inclusion in PubMed and all major indexing services ? Maximum visibility for your research Submit your manuscript at www.biomedcentral, com/submit Submit your next manuscript to BioMed Central and we will help you at every step, 2016.

E. Bar-on, E. Goldberg, A. Fraser, L. Vidal, S. Hellmann et al., Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB), Cochrane Database Syst Rev, issue.3, p.5530, 2009.

G. Passalacqua, I. Baiardini, G. Senna, and G. Canonica, Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis, Clinical & Experimental Allergy, vol.29, issue.Suppl. 6, pp.22-30, 2013.
DOI : 10.1111/j.1365-2222.2012.04052.x

W. Reisacher and J. Visaya, Patient adherence to allergy immunotherapy, Current Opinion in Otolaryngology & Head and Neck Surgery, vol.21, issue.3, pp.256-62, 2013.
DOI : 10.1097/MOO.0b013e32835f8048

S. Kaul, S. May, D. Luttkopf, and S. Vieths, Regulatory environment for allergen-specific immunotherapy, Allergy, vol.96, issue.Suppl. 14, pp.753-64, 2011.
DOI : 10.1111/j.1398-9995.2011.02552.x

O. Pfaar, C. Bachert, A. Bufe, R. Buhl, C. Ebner et al., Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases?S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for, the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD), pp.282-319, 2014.

E. Nony, J. Bouley, L. Mignon, M. Lemoine, P. Jain et al., Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients, Allergy, vol.31, issue.Suppl 2, pp.795-804, 2015.
DOI : 10.1111/all.12622

URL : https://hal.archives-ouvertes.fr/hal-01439031

C. Bachert, M. Larché, S. Bonini, G. Canonica, T. Kündig et al., Allergen immunotherapy on the way to product-based evaluation???a WAO statement, World Allergy Organization Journal, vol.5, issue.1 suppl, 2015.
DOI : 10.1186/s40413-015-0078-8